Literature DB >> 7561161

Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes.

C N Rao1, D A Ladin, Y Y Liu, K Chilukuri, Z Z Hou, D T Woodley.   

Abstract

Fluid obtained from chronic and acute wounds were examined for the presence of fibronectin, alpha 1-antitrypsin, and proteinases capable of degrading both proteins. Immunoblot analysis of fluids from ten chronic wounds revealed that fibronectin and alpha 1-antitrypsin were degraded in nine of ten samples. In contrast, both fibronectin and alpha 1-antitrypsin were intact in acute wound fluids. The degradation of the inhibitor and fibronectin occurred in the same wound fluids, and these two events correlated perfectly. Chronic or acute wound fluid proteins were coupled to benzamidine Sepharose 6B beads and incubated with fibronectin or alpha 1-antitrypsin. Chronic wound fluid proteins degraded fibronectin in the presence of ethylenediaminetetraacetate, leupeptin, cystatin, and pepstatin but not in the presence of phenylmethylsulfonyl fluoride. Acute wound fluids and normal human serum did not contain enzymes capable of degrading fibronectin. These data suggest that serine proteinases are responsible for fibronectin degradation in chronic wound fluids. Chronic wound fluids that contained degraded alpha 1-antitrypsin also contain proteinases capable of degrading alpha 1-antitrypsin from human serum. Acute wound fluids and normal human serum did not contain enzymes capable of degrading alpha 1-antitrypsin. The inhibitor from acute wound fluids bound to one of its targets, trypsin. In contrast, the fragment(s) of alpha 1-antitrypsin from chronic wound fluids did not bind trypsin. Chronic wounds associated with degraded fibronectin and the inhibitor contained ten- to forty-fold more elastase activity than acute wounds. The degradation of fibronectin by chronic wound fluid enzymes was inhibited by alpha 1-antitrypsin in a dose-dependent manner. Collectively, these results demonstrate that there are enzymes in chronic wounds that perturb the function of alpha 1-antitrypsin and allow fibronectin degradation by uninhibited serine proteinases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561161     DOI: 10.1111/1523-1747.ep12323503

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  The use of gauze: will it ever change?

Authors:  Vanessa J Jones
Journal:  Int Wound J       Date:  2006-06       Impact factor: 3.315

2.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 3.  Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.

Authors:  Jacqueline Larouche; Sumit Sheoran; Kenta Maruyama; Mikaël M Martino
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

4.  Prospective and randomised evaluation of the protease-modulating effect of oxidised regenerated cellulose/collagen matrix treatment in pressure sore ulcers.

Authors:  Oliver Kloeters; Frank Unglaub; Erik de Laat; Marjolijn van Abeelen; Dietmar Ulrich
Journal:  Int Wound J       Date:  2015-05-23       Impact factor: 3.315

Review 5.  Biologic therapeutics and molecular profiling to optimize wound healing.

Authors:  Marie N Menke; Nathan B Menke; Cecelia H Boardman; Robert F Diegelmann
Journal:  Gynecol Oncol       Date:  2008-10-01       Impact factor: 5.482

6.  Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.

Authors:  Yuan-Ping Han; Chunli Yan; Warren L Garner
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

7.  Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration.

Authors:  Ralf Smeets; Dietmar Ulrich; Frank Unglaub; Michael Wöltje; Norbert Pallua
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

Review 8.  Neutrophil activity in chronic venous leg ulcers--a target for therapy?

Authors:  Jodi C McDaniel; Sashwati Roy; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-03-28       Impact factor: 3.617

Review 9.  Neutrophils and Wound Repair: Positive Actions and Negative Reactions.

Authors:  Traci A Wilgus; Sashwati Roy; Jodi C McDaniel
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-09       Impact factor: 4.730

10.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair.

Authors:  Wing S To; Kim S Midwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.